Z-1495-2019 Class II Terminated
FDA device recall Z-1495-2019 was initiated by PF Consumer Healthcare 1 LLC on April 26, 2019 and is designated Class II. Reason for recall: There is the potential that a HeatWrap could include cells that have a higher cell temperature than specified in lot S97473. The use of heat cell wrap with increased temperatures poses a potential ris… The recall status is terminated (terminated June 11, 2024). Affected quantity: 155,904 individual HeatWraps.
Recall Details
- Product Type
- Devices
- Report Date
- June 5, 2019
- Initiation Date
- April 26, 2019
- Termination Date
- June 11, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 155,904 individual HeatWraps
Product Description
ThermaCare HEATWRAPS, ADVANCED BACK PAIN THERAPY, UPC 305733010037 - Product Usage: ThermaCare(R) HeatWraps are indicated in adults to provide heat therapy for the temporary relief of minor muscular and joint pains associated with overexertion, strains, sprains, and arthritis and menstrual pain. ThermaCare HeatWraps are made up of heat cells enclosed within wraps that consists of a mixture of ingredients including soft iron, carbon or absorbent gelling material and brine solution (water, salt, and sodium thiosulphate). The heat cells get activated in the presence of air (oxygen) to produce a low-level heat.
Reason for Recall
There is the potential that a HeatWrap could include cells that have a higher cell temperature than specified in lot S97473. The use of heat cell wrap with increased temperatures poses a potential risk of skin injuries such as burns/blisters and/or skin irritation on the wrap-applied area.
Distribution Pattern
Worldwide distribution - US Nationwide and PR, and countries of Ireland, UK, Malta, Netherlands, Germany, and Switzerland.
Code Information
Lot Number S97473